Sildenafil for Erectile Dysfunction: Pivotal Study
New England Journal of Medicine (1998)
Goldstein et al. demonstrated sildenafil significantly improved erectile function across all severity levels vs placebo.
Sildenafil
Oral tablet (20mg, 100mg)Available in all 50 statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
sexual health
The original PDE5 inhibitor with a 4 to 5 hour duration of action, providing on-demand erectile function support. Also FDA-approved for pulmonary arterial hypertension (Revatio).
Rapid onset (30 to 60 minutes)
Well-established efficacy and safety
Available in low-dose for PAH
Generic, cost-effective
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
Selectively inhibits PDE5, enhancing NO-mediated cGMP signaling in penile and pulmonary vascular smooth muscle, causing vasodilation.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
Clinical evidence
New England Journal of Medicine (1998)
Goldstein et al. demonstrated sildenafil significantly improved erectile function across all severity levels vs placebo.
Safety profile
FAQ
The original PDE5 inhibitor with a 4 to 5 hour duration of action, providing on-demand erectile function support. Also FDA-approved for pulmonary arterial hypertension (Revatio).
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.